Home » Topics » Regulatory

Regulatory
RSS

First marketing approval for Novartis transplant drug

April 22, 1998

FDA clears new indication for Prevacid

April 17, 1998

Cosopt receives marketing approval from FDA

April 16, 1998

Antiviral drugs advisory committee will discuss Intron A/Rebetol NDA

April 15, 1998

FDA approves fifth indication for Neupogen

April 14, 1998

Orphan Medical receives approval to market Sucraid in U.S.

April 14, 1998

Expanded indication approved for Proscar

April 8, 1998

FDA approves Actonel for Paget's disease

April 3, 1998

FDA clears pravastatin for stroke prevention

March 31, 1998

FDA approves Viagra; first oral treatment for ED on the way to market

March 30, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...